FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marta López-Parra

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Esther Titos; Natàlia Ferré; Juan José Lozano; Raquel Horrillo; Marta López-Parra; Vicente Arroyo; Joan Clària
Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Raquel Horrillo; Ana González-Périz; Marcos Martínez-Clemente; Marta López-Parra; Natàlia Ferré; Esther Titos; Eva Morán-Salvador; Ramon Deulofeu; Vicente Arroyo; Joan Clària
5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
Marcos Martínez-Clemente; Natàlia Ferré; Ana González-Périz; Marta López-Parra; Raquel Horrillo; Esther Titos; Eva Morán-Salvador; Rosa Miquel; Vicente Arroyo; Colin D Funk; Joan Clària
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marta López-Parra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Esther Titos; Natàlia Ferré; Juan José Lozano; Raquel Horrillo; Marta López-Parra; Vicente Arroyo; Joan Clària
Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Prostaglandins & other lipid mediators 2010;92(1-4):54-61.
2010: Raquel Horrillo; Ana González-Périz; Marcos Martínez-Clemente; Marta López-Parra; Natàlia Ferré; Esther Titos; Eva Morán-Salvador; Ramon Deulofeu; Vicente Arroyo; Joan Clària
5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(7):3978-87.
2010: Marcos Martínez-Clemente; Natàlia Ferré; Ana González-Périz; Marta López-Parra; Raquel Horrillo; Esther Titos; Eva Morán-Salvador; Rosa Miquel; Vicente Arroyo; Colin D Funk; Joan Clària
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.
Hepatology (Baltimore, Md.) 2010;51(3):817-27.
2009: Ana González-Périz; Raquel Horrillo; Natàlia Ferré; Karsten Gronert; Baiyan Dong; Eva Morán-Salvador; Esther Titos; Marcos Martínez-Clemente; Marta López-Parra; Vicente Arroyo; Joan Clària
Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(6):1946-57.
2009: Natàlia Ferré; Marcos Martínez-Clemente; Marta López-Parra; Ana González-Périz; Raquel Horrillo; Anna Planagumà; Jordi Camps; Jorge Joven; Alba Tres; Francesc Guardiola; Ramón Bataller; Vicente Arroyo; Joan Clària
Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols.
American journal of physiology. Gastrointestinal and liver physiology 2009;296(3):G553-62.
2007: Raquel Horrillo; Anna Planagumà; Ana González-Périz; Natàlia Ferré; Esther Titos; Rosa Miquel; Marta López-Parra; Jaime L Masferrer; Vicente Arroyo; Joan Clària
Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
The Journal of pharmacology and experimental therapeutics 2007;323(3):778-86.
2006: Ana González-Périz; Anna Planagumà; Karsten Gronert; Rosa Miquel; Marta López-Parra; Esther Titos; Raquel Horrillo; Natàlia Ferré; Ramon Deulofeu; Vicente Arroyo; Juan Rodés; Joan Clària
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(14):2537-9.
2006: Marta López-Parra; Naiara Telleria; Esther Titos; Anna Planagumà; Ana González-Périz; Vicente Arroyo; Juan Rodés; Joan Clària
Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.
Journal of hepatology 2006;45(2):221-9.
2005: Esther Titos; Joan Clària; Anna Planagumà; Marta López-Parra; Ana González-Périz; Joan Gaya; Rosa Miquel; Vicente Arroyo; Juan Rodés
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Journal of leukocyte biology 2005;78(4):871-8.
2005: Anna Planagumà; Joan Clària; Rosa Miquel; Marta López-Parra; Esther Titos; Jaime L Masferrer; Vicente Arroyo; Juan Rodés
The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(9):1120-2.
2005: Joan Clària; Jeffrey D Kent; Marta López-Parra; Gines Escolar; Luis Ruiz-del-Arbol; Pere Ginès; Wladimiro Jiménez; Boris Vucelic; Vicente Arroyo
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Hepatology (Baltimore, Md.) 2005;41(3):579-87.
2005: Marta López-Parra; Joan Clària; Esther Titos; Anna Planagumà; Marcelina Parrizas; Jaime L Masferrer; Wladimiro Jiménez; Vicente Arroyo; Francisca Rivera; Juan Rodés
The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin.
Journal of hepatology 2005;42(1):75-81.
2003: Esther Titos; Joan Clària; Anna Planagumà; Marta López-Parra; Neus Villamor; Marcelina Parrizas; Ana Carrió; Rosa Miquel; Wladimiro Jiménez; Vicente Arroyo; Francisca Rivera; Juan Rodés
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(12):1745-7.
2003: Marta López-Parra; Joan Clària; Anna Planagumà; Esther Titos; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Wladimiro Jiménez; Vicente Arroyo; Francisca Rivera; Juan Rodés
Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
Advances in experimental medicine and biology 2003;525():133-6.
2002: Anna Planagumà; Esther Titos; Marta López-Parra; Joan Gaya; Gloria Pueyo; Vicente Arroyo; Joan Clària
Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(14):1937-9.
2002: Marta López-Parra; Joan Clària; Anna Planagumà; Esther Titos; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Wladimiro Jiménez; Rosario Altuna; Vicente Arroyo; Francisca Rivera; Juan Rodés
Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
British journal of pharmacology 2002;135(4):891-900.